InvestSMART

Elsight Limited (ASX: ELS) - Announcements

Current share price for ELS : $4.770 0.11 (2.25%)+

ASX company news and announcements for Elsight Limited (ELS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Elsight Limited (ELS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Elsight Limited (ELS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Elsight Limited (ELS)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$1,062 Release of Securities from Escrow 15 Jan 2018 11:31AM $1.250 $4.770 risen by 281.60%
$1,062 Clarification 15 Jan 2018 9:37AM $1.290 $4.770 risen by 269.77%
$1,062 Trading Halt Request 11 Jan 2018 10:49AM $1.290 $4.770 risen by 269.77%
$1,062 Trading Halt 11 Jan 2018 10:39AM $1.290 $4.770 risen by 269.77%
$1,062 First Purchase Order from Autonomous Car Sector 11 Jan 2018 9:15AM $1.290 $4.770 risen by 269.77%
$1,062 Appendix 3B 9 Jan 2018 12:32PM $1.405 $4.770 risen by 239.50%
$1,062 Automotive Robotic Industry Ltd Places Order 8 Jan 2018 9:25AM $1.450 $4.770 risen by 228.97%
$1,062 Appendix 3B 4 Jan 2018 9:45AM $1.460 $4.770 risen by 226.71%
$1,062 Appendix 3B 29 Dec 2017 4:15PM $1.470 $4.770 risen by 224.49%
$1,062 Release of Securities from Escrow 12 Dec 2017 11:38AM $1.140 $4.770 risen by 318.42%
$1,062 Elsight Unveils Civilian Vertical Market Solutions 29 Nov 2017 9:30AM $1.500 $4.770 risen by 218%
$1,062 Elsight Welcomes Zvi Hauser Adv. to Advisory Board 27 Nov 2017 10:46AM $1.760 $4.770 risen by 171.02%
$1,062 TMT Analytics Evaluation of Elsight 27 Nov 2017 9:15AM $1.510 $4.770 risen by 215.89%
$1,062 Investor Presentation 27 Nov 2017 8:39AM $1.510 $4.770 risen by 215.89%
$1,062 Elsight Hosts Expert Cybersecurity Delegation from Australia 6 Nov 2017 9:43AM $0.730 $4.770 risen by 553.42%
$1,062 Appendix 4C - Quarterly & Activity Report 30 Oct 2017 11:42AM $0.800 $4.770 risen by 496.25%
$1,062 Correction to Article in Globes-Israel's Business Arena 18 Oct 2017 9:44AM $0.880 $4.770 risen by 442.05%
$1,062 Alrena Agreement Comes into Force, Increases in Value 4 Oct 2017 9:48AM $0.345 $4.770 risen by 1,282.61%
$1,062 Elsight to enter lucrative market of Autonomous Vehicles 3 Oct 2017 11:57AM $0.310 $4.770 risen by 1,438.71%
$1,062 Appendix 4D & Half-Year Financial Statements 31 Aug 2017 5:16PM $0.200 $4.770 risen by 2,285%
$1,062 Hikvison and Elsight to Form Strategic Alliance 29 Aug 2017 9:15AM $0.190 $4.770 risen by 2,410.53%
$1,062 Elsight Awarded Strategic Israeli Police & Government Tender 10 Aug 2017 2:51PM $0.190 $4.770 risen by 2,410.53%
$1,062 Trading Halt 9 Aug 2017 9:24AM $0.190 $4.770 risen by 2,410.53%
$1,062 Elsight and Alrena Agree to Jointly Offer New SmartMedicase 2 Aug 2017 9:14AM $0.175 $4.770 risen by 2,625.71%
$1,062 Appendix 4C - Quarterly & Activity Report 31 Jul 2017 10:24AM $0.150 $4.770 risen by 3,080%

576 - 600 of 631 results

Page 24 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.